Clinical trials for Alzheimer's disease (AD) are slower to enroll study participants, take longer
to complete, and are more expensive than trials in most other therapeutic areas. The …

Abstract Although Hispanic/Latino older adults are at disproportionate and increased risk for
Alzheimer's disease and related dementias, few evidence-based supportive care …

Background Sleep phenotypes have been reported to be associated with cognitive ageing
outcomes. However, there is limited research using genetic variants as proxies for sleep …

Introduction This perspective paper addresses the US Hispanic/Latino (herein, Latino)
experience with regards to a significant public health concern—the underrepresentation of …

Abstract Introduction Despite evidence that Hispanic/Latino populations are 1.5 times more
likely than non‐Latino Whites to develop Alzheimer's disease and related dementias …

Abstract The coronavirus disease 19 (COVID‐19) pandemic has created significant and new
challenges for the conduct of clinical research involving older adults with Alzheimer's …

Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD) are the
primary public health concerns in the United States and around the globe. AD/ADRD are …

Abstract STAR-Caregivers Virtual Training and Follow-up (STAR-VTF) is an evidence-based
intervention that teaches family caregivers how to manage behavioral and psychological …

Importance Patient withdrawal of consent from a cancer clinical trial is defined as a patient's
volitional cessation of participation in all matters related to a trial. It can undermine the trial's …

Objectives Hispanic adults display a higher likelihood of early-stage cognitive decline than
their White counterparts yet receive fewer clinical diagnoses. This troubling trend highlights …